Despite the above-described results were attributed to the GOF activities displayed by mutp53 [124], work in myeloid malignancies showed no evidence of GOF for missense mutations found in p53 in human cancers and rather pointed to the DNE effect as the cause of impaired p53 function [7,127]. Here, TP53 is linked to cancer.